Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
A per-protocol approach was used in the analyses
Conflict of interest JD is a paid consultant for the Stryker Corporation, has intellectual property rights with Elucida Oncology and equity interest in Welwaze Medical, LLC, and has a royalty agreement with Springer Publishers for Multimodal Management of Upper and Lower Extremity Lymphedema
Recommended dose: 1,000 to 1,200 mg daily from food and supplements combined
We do NOT manufacture this medication and have no direct affiliation with Eli Lilly and Company
US$ 24.72
US$ 25.71
US$ 24.99
